Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 7, 2006, Pages 535-540

  Sato, Koichi ^a   Dohi, Yasuaki ^b   Kojima, Masayoshi ^b   Miyagawa, Koichi ^b   Takase, Hiroyuki ^b   Katada, Eiichi ^c   Suzuki, Shin ^a  

^a Johoku Municipal Hospital of Nagoya   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c Tsushima City Hospital   (Japan)

Author keywords

Antihypertensives; Antioxidants; Ascorbic acid, effects on blood pressure, elderly hypertensive patients; Blood pressure monitoring, ambulatory; CAS 50 81 7; Refractory hypertension

Indexed keywords

8 ISOPROSTANE; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; OXIDATIVE STRESS; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE;

EID: 33746869331     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296748     Document Type: Article

References (34)

1. Nakazono, K., Watanabe, N., Matsuno, K. et al., Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA 88, 10045 (1991)
2. Salonen, J. T., Salonen, R., Ihanainen, M. et al., Blood pressure, dietary fats, and antioxidants. Am. J. Clin. Nutr. 48, 1226 (1998)
3. Kalpana, T., Karunakar, N., Redddy, M. S. et al., Assessment of antioxidant activity of some antileprotic drugs. Arzneim.-Forsch./Drug Res. 51, 633 (2001)
4. Karunakar, N., Prabhakar, M. C., Krishna, D. R., Determination of antioxidant activity of some drugs using high-pressure liquid chromatography. Arzneim.-Forsch./Drug Res. 53, 254 (2003)
5. Enstrom, J. E., Kanim, L. E., Klein, M. A., Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3, 194 (1992)
6. Mostafa, S. E., Garner, D. D., Garrett, L. et al., Beneficial effects of vitamin C on risk factors of cardiovascular disease. J. Egypt. Public Health Assoc. 64, 123 (1989)
7. Osilesi, O., Trout, D. L., Ongunwole, J. O. et al., Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nutr. Res. 11, 405 (1991)
8. Duffy, S. J., Gokce, N., Holbrook, M. et al., Treatment of hypertension with ascorbic acid. Lancet 354, 2048 (1999)
9. Mullan, B. A., Young, I. S., Fee, H. et al., Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 40, 804 (2002)
10. Lovat, L. B., Lu, Y. Palmer, A. J. et al., Double-blind trial of vitamin C in elderly hypertensives. J. Hum. Hypertens. 7, 403 (1993)
11. Ghosh, S. K., Ekpo, E. B., Shah, I. U. et al., A double-blind placebo-controlled parallel trial of vitamin C treatment in elderly patients with hypertension. Gerontology 40, 268 (1994)
12. Kim, M. K., Sasaki, S., Sasazuki, S. et al., Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 40, 797 (2001)
13. Luscher, T. F., Tanner, F. C., Dohi, Y., Age, hypertension and hypercholesterolaemia alter endothelium-dependent vascular regulation. Pharmacol. Toxicol. 70, S32 (1992)
14. Dohi, Y., Kojima, M., Sato, K. et al., Age-related changes in vascular smooth muscle and endothelium. Drugs Aging 7, 278 (1995)
15. Junqueira, V. B., Barros, S. B., Chan, S. S. et al., Aging and oxidative stress. Mol. Aspects Med. 25, 5 (2004)
16. Benetos, A., Adamopoulos, C., Bureau, J. M. et al., Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 105, 1202 (2002)
17. Mitchell, G. F., Arterial stiffness and wave reflection in hypertension: pathophysiologic and therapeutic implications. Curr. Hypertens. Rep. 6, 436 (2004)
18. Tomiyama, H., Arai, T., Koji, Y. et al., The age-related increase in arterial increase in arterial stiffness is augmented in phases according to the severity of hypertension. Hypertens. Res. 27, 465 (2004)
19. Setaro, J., Black, H., Refractory hypertension. N. Engl. J. Med. 327, 534 (1992)
20. Rifai, N., Tracy, R. P., Ridker, P. M., Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45, 2136 (1999)
21. Lykkesfeldt, J., Loft, S., Poulsen, H. E., Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection - Are they reliable biomarkers of oxidative stress? Anal. Biochem. 229, 329 (1995)
22. Walsh, S. W, Vaughan, J. E., Wang, Y. et al., Placental isoprostane is significantly increased in preeclampsia. FASEB. J. 14, 1289 (2000)
23. Kitano, S., Kanno, T., Maekawa, M. et al., Improved method for the immunological detection of malondiadehyde-modified low-density lipoproteins in human serum. Anal. Chim. Acta. 509, 229 (2004)
24. Ness, A. R., Chee, D., Elliott, P., Vitamin C and blood pressure-an overview. J. Hum. Hypertens. 11, 343 (1997)
25. Ness, A. R., Sterne, J., Hypertension and ascorbic acid. Lancet 355, 1271 (2000)
26. Svetkey, L. P., Loria, C. M., Blood pressure effects of Vitamin C What's the key question? Hypertension 40, 789 (2002)
27. Wissler, R. W., Robert, L., Aging and cardiovascular disease. Circulation 93, 1608 (1996)
28. Lakatta, E. G., Levy, D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. I: aging arteries: a 'set up' for vascular disease. Circulation 107, 139 (2003)
29. Lakatta, E. G., Levy, D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. II: aging heart in health:links to heart disease. Circulation 107, 346 (2003)
30. Reneman, R. S., Hoeks, A. P. G., Westerhof, N., Non-invasive assessment of artery wall properties in humans-methods and interpretation. J. Vasc. Invest. 2, 53 (1996)
31. Arnett, D. K., Evans, G. W., Riley, W. A., Arterial stiffness: a new cardiovascular risk factor? Am. J. Epidemiol. 140, 669 (1994)
32. Libby, P., Inflammation in atherosclerosis. Nature 420, 868 (2002)
33. Harrison, D., Griendling, K. K., Landmesser, U. et al., Role of oxidative stress in atherosclerosis. Am. J. Cardiol. 91, 7A (2003)
34. Massey, L. K., Ascorbate increases human oxaluria and kidney stone risk. J. Nutr. 135, 1673 (2005)